Suppliers / Hikma Pharmaceuticals

Hikma Pharmaceuticals

Jordan 2 duplicate records merged Updated 9 July 2026

The public registers hold a second record for Hikma Pharmaceuticals. The fuller profile, with 0 active US DMFs and 1 valid CEPs, is at Hikma Pharmaceuticals. Figures on this page cover only this record.

Hikma Pharmaceuticals is a finished-dose manufacturer based in Jordan. It appears in 10 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
10
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Gilteritinib SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Resmetirom finished dose Vibegron finished dose

Filings and GMP by regulator

Regulator Filings GMP certificates
JFDA (JO) 10 None

Questions about Hikma Pharmaceuticals

Does Hikma Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Hikma Pharmaceuticals. It does have 10 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
What does Hikma Pharmaceuticals make?
1 molecule is on record against Hikma Pharmaceuticals, including Gilteritinib. Each links through to that molecule's full manufacturer list.
Where does Hikma Pharmaceuticals file?
Filings are on record with JFDA (JO), 10 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Hikma Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hikma Pharmaceuticals also in Jordan

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability